Skip to main content

Find Clinical Trials

Home
Conditions
Urticaria

Clinical trial condition

Urticaria

Explore clinical trials studying Urticaria. Study availability and eligibility vary by location and protocol.

320 public trials 40 recruiting studies

Refine in advanced search Browse all conditions

Urticaria trial results

Completed

A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor

NCT01760343

Conditions: Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +9 more
Locations: Study Site Berlin, Germany

View Trial Details

Completed

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

NCT00225147

Conditions: Angioedema, Angioedemas, Hereditary, Angioneurotic Edema, +15 more
Locations: For information on sites please contact Pharming Medical Affairs Department Leiden, Netherlands

View Trial Details

Completed

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

NCT00262301

Conditions: Angioedema, Angioedemas, Hereditary, Angioneurotic Edema, +16 more
Locations: For information on sites, please contact Pharming Medical Affairs Deparment Leiden, Netherlands

Emergency County Hospital, Internal Medicin Clinica, Allergology-Immunology Department Târgu Mureş, Romania

View Trial Details

Completed

Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)

NCT01045772

Conditions: Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +21 more
Locations: Charité University Hospital Berlin, State of Berlin, Germany

View Trial Details

Completed

AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Study

NCT01154361

Conditions: Angioedema, Cardiovascular Diseases, Hypersensitivity, +7 more
Locations: Klinikum rechts der Isar Hals-Nasen-Ohrenklinik der TUM Munich, Bavaria, Germany

View Trial Details

Completed

Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)

NCT00288704

Conditions: Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +19 more
Locations: Little Rock, Arkansas, United States

Palm Desert, California, United States

Upland, California, United States

Jacksonville, Florida, United States

View all 24 locations

View Trial Details

Completed

Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria

NCT00481676

Conditions: Chronic Disease, Chronic Urticaria, Disease Attributes, +10 more
Locations: Novartis Investigative Site Berlin, Germany

Novartis Investigative Site Bonn, Germany

Novartis Investigative Site Cologne, Germany

Novartis Investigative Site Dresden, Germany

View Trial Details

Completed

CUTE (Chronic Urticaria Treatment Evaluation)

NCT00264303

Conditions: Chronic Disease, Chronic Idiopathic Urticaria, Chronic Urticaria, +10 more
Locations: Bruges, Belgium

Brussels, Belgium

Liège, Belgium

Merksem, Belgium

View all 80 locations

View Trial Details

Completed

In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia

NCT00785018

Conditions: Angioedema, Angioedemas, Hereditary, Bacteremia, +23 more
Locations: Radboud University Nijmegen Medical Centre Nijmegen, Netherlands

View Trial Details

Completed

Berinert P Study of Subcutaneous Versus Intravenous Administration

NCT00748202

Conditions: Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations: Centre of Paediatrics III, Department of Haematology, Haemostaseology and Oncology, Comprehensive Care Centre for Thrombosis and Haemostasis, Johann-Wolfgang-Goethe-University Hospital Frankfurt am Main, Hesse, Germany

View Trial Details